Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence

被引:75
作者
Palareti, G [1 ]
Legnani, C [1 ]
Cosmi, B [1 ]
Guazzaloca, G [1 ]
Cini, M [1 ]
机构
[1] Univ Hosp S Orsola Malpighi, Dept Angiol & Blood Coagulat, I-40138 Bologna, Italy
关键词
monitoring; quality; recurrence; thrombosis; venous thromboembolism; warfarin;
D O I
10.1111/j.1538-7836.2005.01330.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Aim: Several factors are associated with an increased risk of recurrent venous thromboembolism (VTE). The aim of the study was to investigate whether the quality of oral anticoagulation therapy (OAT) is a long-term risk factor for recurrence of VTE after OAT interruption. Methods and results: A total of 297 patients (170 males) with a recent acute unprovoked VTE episode were prospectively monitored during OAT in our anticoagulation clinic and followed up for 21 months after OAT interruption. Recurrent events were recorded in 42 subjects for 493 years of follow-up [14.1% of patients; 8.5% patient-years (pt-y)] after OAT withdrawal. The rate of recurrence was not correlated to OAT duration. Subjects experiencing recurrence after OAT interruption had spent significantly more time at markedly subtherapeutic international normalized ratio (INR) levels (< 1.5) and less time within the therapeutic range (2.0-3.0 INR) during OAT. Relative risk (RR) of recurrence was significantly higher [2.77 (95% confidence interval (CI) 1.49-5.18; P = 0.001) and 2.70 (95% CI 1.39-5.25; P = 0.003) at univariate and multivariate analysis, respectively] in those who spent more time (upper quintile) at INR values < 1.5, being especially evident in the first 90 days of OAT. RR was significantly higher at univariate [2.05 (95% CI 1.07-3.96; P = 0.031)] but not at multivariate [1.98 (95% CI 0.98-4.0; P = 0.056)] analysis when the entire OAT period was considered. Subjects in the upper quintile of time spent at INR values < 1.5 had significantly higher D-dimer values when OAT was stopped and after 3 months. Conclusions: The amount of time that subjects with an acute unprovoked WE event spend at near-normal INR values (< 1.5) during the first 3 months of treatment is associated with higher D-dimer values measured during OAT and after its interruption and is a significant risk factor for late VTE recurrence.
引用
收藏
页码:955 / 961
页数:7
相关论文
共 29 条
  • [1] Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis.
    Agnelli, G
    Prandoni, P
    Santamaria, MG
    Bagatella, P
    Iorio, A
    Bazzan, M
    Moia, M
    Guazzaloca, G
    Bertoldi, A
    Tomasi, C
    Scannapieco, G
    Ageno, W
    Ascani, A
    Villalta, S
    Frulla, M
    Mosena, L
    Girolami, A
    Vaccarino, A
    Alatri, A
    Palareti, G
    Marchesi, M
    Ambrosio, GB
    Parisi, R
    Doria, S
    Steidl, L
    Ambrosini, F
    Silingardi, M
    Ghirarduzzi, A
    Iori, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) : 165 - 169
  • [2] The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin
    Anand, S
    Ginsberg, JS
    Kearon, C
    Gent, M
    Hirsh, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (15) : 1677 - 1681
  • [3] Recurrent venous thrombosis and heparin therapy -: An evaluation of the importance of early activated partial thromboplastin times
    Anand, SS
    Bates, S
    Ginsberg, JS
    Levine, M
    Buller, H
    Prins, M
    Haley, S
    Kearon, C
    Hirsh, J
    GEnt, M
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (17) : 2029 - 2032
  • [4] ACENOCOUMAROL AND HEPARIN COMPARED WITH ACENOCOUMAROL ALONE IN THE INITIAL TREATMENT OF PROXIMAL-VEIN THROMBOSIS
    BRANDJES, DPM
    HEIJBOER, H
    BULLER, HR
    DERIJK, M
    JAGT, H
    TENCATE, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) : 1485 - 1489
  • [5] Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
    Douketis, JD
    Kearon, C
    Bates, S
    Duku, EK
    Ginsberg, JS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06): : 458 - 462
  • [6] Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy
    Douketis, JD
    Foster, GA
    Crowther, MA
    Prins, MH
    Ginsberg, JS
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (22) : 3431 - 3436
  • [7] D-dimer levels and risk of recurrent venous thromboembolism
    Eichinger, S
    Minar, E
    Bialonczyk, C
    Hirschl, M
    Quehenberger, P
    Schneider, B
    Weltermann, A
    Wagner, O
    Kyrle, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (08): : 1071 - 1074
  • [8] The evaluation of suspected pulmonary embolism
    Fedullo, PF
    Tapson, VF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13) : 1247 - 1256
  • [9] GALLUS A, 1986, LANCET, V2, P1293
  • [10] Recurrent venous thromboembolism after deep vein thrombosis -: Incidence and risk factors
    Hansson, PO
    Sörbo, J
    Eriksson, H
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (06) : 769 - 774